The Principal Investigator of the proposed CTO is Dr. Mauro Ferrari, Chairman of Biomedical Engineering, Director of the Division of Nanomedicine, and Professor of Internal Medicine at UTHSC-H. Dr. Ferrari holds concurrent faculty appointments at MDACC, Rice U and UTA, and is the President of the Alliance for NanoHealth. He is trained in mathematics, mechanical engineering and medicine. He is a recognized leader in the development and application of biomedical nanotechnology. Co-leading the CTO is Senior Colnvestigator, Dr. Steven Curiey of MDACC, Professor and Chief, Gastrointestinal Tumor Surgery, Program Director, Gastrointestinal Tumor Multidisciplinary Care Center and the Charles B. Barker Chair in Surgery. He is a renowned Gl tumor surgeon and physician scientist. Drs. Ferrari and Curiey will lead the proposed CTO from the physical sciences and clinical and oncology sciences, respectively. Both have demonstrated experience to conduct and lead multidisciplinary research programs that bridge the physical sciences and biomedical and clinical sciences. CTO Center Administrative Unit, led by the PI and Senior Co-lnvestigator will be assisted by a Center Manager, Dr. Jason Sakamoto, to provide leadership and general administration for all activities related to this proposed CTO. Dr. Apostolia Tsimberidou, Assitant Professor at MDACC, will be Director of Clinical Translation, Education and Outreach. She will guide and advise the investigators in their research toward clinical translation. CTO Center Administrative Unit is responsible for: 1) providing administrative support to all projects and core resources of the CTO, 2) providing administrative support to develop and manage pilot project programs (Internal pilot projects-CAC, TransNetwork pilot projects-PSC, and external pilot projects-outreach), 3) convening CTO team meetings, CAC meetings, as well as scientific conferences and workshops, 4) supporting the participation of the CTO in PS-OC network and communicate with NCI staff, facilitate and prepare the CTO participation in NCI evaluation, 5) facilitating communication with other PS-OCs, and among other administrative and supportive functions, and 6) interfacing with other administrative resources and shared core facilities in the participating institutions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA143837-05
Application #
8379712
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
2012-09-24
Project End
2014-07-31
Budget Start
2012-09-24
Budget End
2013-07-31
Support Year
5
Fiscal Year
2012
Total Cost
$106,290
Indirect Cost
Name
Methodist Hospital Research Institute
Department
Type
DUNS #
185641052
City
Houston
State
TX
Country
United States
Zip Code
77030
Mai, Junhua; Li, Xin; Zhang, Guodong et al. (2018) DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement. Mol Pharm 15:1814-1825
Krzykawska-Serda, Martyna; Agha, Mahdi S; Ho, Jason Chak-Shing et al. (2018) Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts. Transl Oncol 11:664-671
Tang, Chad; Hobbs, Brian; Amer, Ahmed et al. (2018) Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep 8:1922
Wang, Feng; Xia, Xiaojun; Yang, Chunying et al. (2018) SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Clin Cancer Res 24:3176-3185
Kojic, M; Milosevic, M; Kojic, N et al. (2018) Mass release curves as the constitutive curves for modeling diffusive transport within biological tissue. Comput Biol Med 92:156-167
Koay, Eugene J; Lee, Yeonju; Cristini, Vittorio et al. (2018) A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 24:5883-5894
Mu, Chaofeng; Wu, Xiaoyan; Zhou, Xinyu et al. (2018) Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer. Clin Cancer Res 24:4900-4912
Amer, Ahmed M; Zaid, Mohamed; Chaudhury, Baishali et al. (2018) Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124:1701-1709
Koay, Eugene J; Hall, William; Park, Peter C et al. (2018) The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY) 43:393-403
Martinez, Jonathan O; Molinaro, Roberto; Hartman, Kelly A et al. (2018) Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics 8:1131-1145

Showing the most recent 10 out of 255 publications